controllers 发表于 2025-3-21 20:03:23

书目名称Biomarkers in Carcinoma of Unknown Primary影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0187808<br><br>        <br><br>书目名称Biomarkers in Carcinoma of Unknown Primary读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0187808<br><br>        <br><br>

消息灵通 发表于 2025-3-21 23:25:06

Book 2022is and treatment decision, especially when faced with a carcinoma of unknown primary. For this purpose, epithelial malignancies of all systems and related biomarkers are examined one by one, and to look at the subject through the metastatic regions window, biomarkers that can be used to determine th

GAVEL 发表于 2025-3-22 01:57:08

http://reply.papertrans.cn/19/1879/187808/187808_3.png

收养 发表于 2025-3-22 08:32:53

Michael Stiels-Glenn,Penelope Glenn general clinic of cancer patients of unknown primary. Empirical chemotherapy regimens have been developed for the cancer of unknown primary, and a broad-spectrum chemotherapy regimen partially benefited, but today’s medicine that allows personalized treatments requires a definitive, pathological, and even molecular diagnosis.

Thrombolysis 发表于 2025-3-22 10:20:01

http://reply.papertrans.cn/19/1879/187808/187808_5.png

Ingenuity 发表于 2025-3-22 14:53:20

http://reply.papertrans.cn/19/1879/187808/187808_6.png

矿石 发表于 2025-3-22 19:18:17

Management of the Patients with Carcinoma of Unknown Primary and the Role of Biomarkers, general clinic of cancer patients of unknown primary. Empirical chemotherapy regimens have been developed for the cancer of unknown primary, and a broad-spectrum chemotherapy regimen partially benefited, but today’s medicine that allows personalized treatments requires a definitive, pathological, and even molecular diagnosis.

残酷的地方 发表于 2025-3-23 00:39:58

http://reply.papertrans.cn/19/1879/187808/187808_8.png

collateral 发表于 2025-3-23 04:02:46

Book 2022ma. The importance of biomarkers in patient follow-up and treatment is also conveyed through the clinician‘s eye, and so biomarkers are handled with a holistic approach in all aspects. This book primarily targets pathologists, as well as clinicians (oncologists and surgeons) who manage cancer patients.

critique 发表于 2025-3-23 09:03:52

Konfrontation oder Kooperation?nsitivity, and specificity of biomarkers are described internationally, and a biomarker should meet all these criteria being used in patient care. Immunohistochemistry, in situ hybridization, polymerase chain reaction, sequencing, and bioinformatic facilities are required for proper diagnosis in a pathology laboratory.
页: [1] 2 3 4 5 6
查看完整版本: Titlebook: Biomarkers in Carcinoma of Unknown Primary; Sulen Sarioglu,Ozgul Sagol,Anil Aysal Book 2022 The Editor(s) (if applicable) and The Author(s